A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Lumiracoxib
Empagliflozin
The therapeutic efficacy of Empagliflozin can be increased when used in combination with Vemurafenib.
Lumiracoxib
Benfluorex
The therapeutic efficacy of Benfluorex can be increased when used in combination with Vemurafenib.
Lumiracoxib
Gosogliptin
The therapeutic efficacy of Gosogliptin can be increased when used in combination with Vemurafenib.
Lumiracoxib
Liraglutide
The therapeutic efficacy of Liraglutide can be increased when used in combination with Vemurafenib.
Lumiracoxib
Bisegliptin
The therapeutic efficacy of Bisegliptin can be increased when used in combination with Vemurafenib.
Lumiracoxib
AMG-222
The therapeutic efficacy of AMG-222 can be increased when used in combination with Vemurafenib.
Lumiracoxib
NBI-6024
The therapeutic efficacy of NBI-6024 can be increased when used in combination with Vemurafenib.
Lumiracoxib
NN344
The therapeutic efficacy of NN344 can be increased when used in combination with Vemurafenib.
Lumiracoxib
Voglibose
The therapeutic efficacy of Voglibose can be increased when used in combination with Vemurafenib.
Lumiracoxib
Vildagliptin
The therapeutic efficacy of Vildagliptin can be increased when used in combination with Vemurafenib.
Lumiracoxib
AICA ribonucleotide
The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Vemurafenib.
Lumiracoxib
Glymidine
The therapeutic efficacy of Glymidine can be increased when used in combination with Vemurafenib.
Lumiracoxib
Insulin glulisine
The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Vemurafenib.
Lumiracoxib
Insulin detemir
The therapeutic efficacy of Insulin detemir can be increased when used in combination with Vemurafenib.
Lumiracoxib
Insulin aspart
The therapeutic efficacy of Insulin aspart can be increased when used in combination with Vemurafenib.
Lumiracoxib
Nabiximols
Nabiximols may decrease the excretion rate of Vemurafenib which could result in a higher serum level.
Lumiracoxib
Cannabidiol
Cannabidiol may decrease the excretion rate of Vemurafenib which could result in a higher serum level.
Lumiracoxib
Fimasartan
Vemurafenib may decrease the excretion rate of Fimasartan which could result in a higher serum level.
Lumiracoxib
Riociguat
Vemurafenib may decrease the excretion rate of Riociguat which could result in a higher serum level.
Lumiracoxib
Isavuconazole
The serum concentration of Vemurafenib can be increased when it is combined with Isavuconazole.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3